http://localhost:8080/xmlui/handle/123456789/9116 183 - 357 2026-04-15T03:03:33Z http://localhost:8080/xmlui/handle/123456789/9212 Title: Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013e2020) Authors: Kurskaya, O.G.; Prokopyeva, E.A.; Anoshina, , A.V.; Leonova, N.V.; Simkina, , O.A.; Komissarova, T.V. Abstract: Abstract We investigated the incidence of 15 respiratory viruses among 2991 children with acute respiratory infections in Novosibirsk city, Russia, prior to the COVID-19 pandemic (2013e2020). Viral infections were detected in 72.5% cases. The incidence of human coronavirus was 2% (Alphacoronaviruses, 63%; Betacoronaviruses, 37%). 2022-04-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/9205 Title: Hemodialysis acutely altered interferongamma release assay test result and immune cell profile Authors: Utami Putri, Denise; Chen, Chia-Ling; -Hui Wang, Cheng; Mou Sue, Yuh-; Tseng, Po-Chun; -Feng Lin, Chiou Abstract: Abstract Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive patients showed significant decrease in quantitative IGRA result with alterations inCD3þCD4þCD45ROþ, NK cell, and monocyte subsets immediately upon HD procedure. Our result suggested that the timing of IGRA testing is crucial in end-stage renal disease population. 2022-04-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/9203 Title: Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers Authors: Kweon, Oh Joo; Kwan Lim, Yong; Ryoun Kim, Hye; -Hyoung Kim, Tae; Lee, Mi-Kyung Abstract: Abstract The ichroma IGRA-TB (Boditech Med Inc., Chuncheon, Republic of Korea) is an automated fluorescent immunoassay-based point-of-care interferon-gamma release assay for detecting latent tuberculosis infection. We evaluated this assay with 408 health care workers, and demonstrated its acceptable performances comparing to QuantiFERON-TB Gold-Plus (QFTPlus; Qiagen, Germantown, MD). 2022-04-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/9200 Title: Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan Authors: Cheng, Chao-Neng; Li, Sin-Syue; Yeh, Yun-Hsuan; Shen, Ching-Fen; -Shiuh Chen, Jiann Abstract: Abstract From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted. 2022-04-01T00:00:00Z